Isabelle Hemington

Board Member at Create Wellness

London, England, United Kingdom

Overview

Isabelle Hemington is a Principal at Unilever Ventures, focusing on early-stage investments in the wellness and beauty sectors across North America and Europe. A graduate of the University of Bristol, she has over a decade of experience with high-growth consumer brands, including prior roles in investment banking at J. P. Morgan.

Isabelle is a vocal advocate for innovation in womens health, participating in industry panels and backing companies that address under-researched and underserved areas. Her work involves partnering closely with mission-driven founders to build trusted, science-backed brands that resonate with modern consumers.

She is passionate about closing the funding and research gap in womens health, a mission that guides her investment strategy.

Topics They Care About

Women's Health
Actively invests in and supports brands like Perelel that aim to close the research and product gap in women's reproductive health.
Wellness Supplements
Invests in science-backed companies such as Thesis (nootropics) and Create Wellness (creatine) that focus on cognitive and physical performance.
FemTech Innovation
Participates in industry events and panels, such as "Decoding the Future of Women, " to champion and discuss innovation in the sector.

Media Appearances

Isabelle has no verified media appearances

Work History

8-2024
Board Member at Create Wellness
4-2023
Board Member at Thesis
10-2022
Board Member at Live Tinted
8-2022
Board Member at STRAAND
4-2022
Board Member at Perelel

Education

2009 - 2012
Bachelor of Science (B.Sc.) from University of Bristol

More Information

Social Presence :

Prographics :

Exp : 16 Location : London, England, United Kingdom Job Level : Mid-senior Designation : Board Member at Create Wellness
URL has been copied!

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.